SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-041393
Filing Date
2021-08-10
Accepted
2021-08-10 16:31:06
Documents
2
Period of Report
2021-08-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea145550-8k_180lifesciences.htm 8-K 19864
2 AMENDED AND RESTATED BYLAWS OF 180 LIFE SCIENCES CORP. ea145550ex3-1_180lifescience.htm EX-3.1 134995
  Complete submission text file 0001213900-21-041393.txt   156091
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 211160332
SIC: 2834 Pharmaceutical Preparations